RECURSION PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $1.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $1.33M, a 95.48% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$10.05M, a 146.16% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $2.62M.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$9.53M.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $44.35M.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$7.64M.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- RECURSION PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $126.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.33M 10-Q · filed 2026-08-05 | -$8.72M 10-Q · filed 2026-08-05 | -$6.10M derived: sum of 3 quarters · filed 2026-08-05 | -$15.63M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.05M 10-Q · filed 2026-05-06 | -$7.43M derived: sum of 2 quarters · filed 2026-05-06 | -$16.96M derived: sum of 3 quarters · filed 2026-05-06 | $12.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$6.90M derived: sum of 2 quarters · filed 2026-02-25 | $22.57M derived: sum of 3 quarters · filed 2026-08-05 | $44.35M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$9.53M 10-Q · filed 2025-11-05 | $19.95M derived: sum of 2 quarters · filed 2026-08-05 | $41.73M 10-Q · filed 2025-11-05 | $34.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $29.48M 10-Q · filed 2026-08-05 | $51.26M 10-Q · filed 2026-08-05 | $43.62M derived: sum of 3 quarters · filed 2026-08-05 | $43.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $21.78M 10-Q · filed 2026-05-06 | $14.14M derived: sum of 2 quarters · filed 2026-05-06 | $14.14M derived: sum of 3 quarters · filed 2026-05-06 | $14.14M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$7.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$7.64M derived: sum of 2 quarters · filed 2026-02-25 | -$7.64M derived: sum of 3 quarters · filed 2026-02-25 | -$7.64M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $197.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $197.00K derived: sum of 3 quarters · filed 2025-02-28 | $309.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $197.00K derived: sum of 2 quarters · filed 2025-02-28 | $309.00K derived: sum of 3 quarters · filed 2025-02-28 | $126.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $197.00K 10-Q · filed 2023-11-09 | $309.00K derived: sum of 2 quarters · filed 2023-11-09 | $126.00K 10-Q · filed 2023-11-09 | -$2.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $112.00K 10-Q · filed 2023-08-08 | -$71.00K 10-Q · filed 2023-08-08 | -$199.00K derived: sum of 3 quarters · filed 2024-02-29 | -$197.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$183.00K 10-Q · filed 2023-05-08 | -$311.00K derived: sum of 2 quarters · filed 2024-02-29 | -$309.00K derived: sum of 3 quarters · filed 2024-02-29 | -$309.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$126.00K derived: sum of 2 quarters · filed 2024-02-29 | -$126.00K derived: sum of 3 quarters · filed 2024-02-29 | -$126.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-08 | $2.00K derived: sum of 2 quarters · filed 2022-11-08 | $2.00K 10-Q · filed 2022-11-08 | $2.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |